Stay Updated About Exelixis

Subscribe to receive news via email.

Exelixis History

Learn more about the chronology of Exelixis

Learn more about our drugs in development

XL184

XL228

XL281

XL765

More

What's new at Exelixis? Our approach. Our Strategy.
Our results.

We are committed to providing the media with timely and accurate information. We have designed this section of the site to be a resource for members of the media.

Charles Butler

Executive Director, Corporate Communications & Investor Relations
650 837 7277 phone
650 837 8205 fax
cbutler@exelixis.com

Soleil Maxwell Harrison

Senior Manager, Corporate Communications
650 837 7012 phone
650 837 8205 fax
sharrison@exelixis.com